Almoosa Health Company Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	236.54	49.35	98.15	51.02	62.42
Depreciation & Amortization	94.6	81.73	64.76	56.94	28.49
Other Amortization	2.29	2.62	3.53	2.65	1.46
Loss (Gain) From Sale of Assets	-0.22	-0.11	-0.33	-0.03	0.07
Asset Writedown & Restructuring Costs	-	-	-	0.01	0.01
Loss (Gain) From Sale of Investments	6.36	-	-	-	-
Loss (Gain) on Equity Investments	-0.54	-1.19	-	-	-
Provision & Write-off of Bad Debts	6.84	4.41	3.93	-0.17	1.22
Other Operating Activities	-17.16	70.45	10.36	14.93	12.08
Change in Accounts Receivable	-138.17	-42.3	-166.81	-66.22	-10.71
Change in Inventory	-9.95	-8.81	-9.29	-0.16	-7.77
Change in Accounts Payable	-17.36	-1.1	3.15	-49.76	75.25
Change in Other Net Operating Assets	17.58	-15.38	32.62	-20.19	35.21
Operating Cash Flow	180.83	139.67	40.07	-10.97	197.72
Operating Cash Flow Growth	29.47%	248.56%	-	-	31.88%
Capital Expenditures	-465.1	-196.32	-383.19	-307.18	-318.47
Sale of Property, Plant & Equipment	2.65	1.36	23.07	0.03	0.02
Sale (Purchase) of Intangibles	-3.14	-6.33	-2.16	-2.89	-0.31
Sale (Purchase) of Real Estate	-62.79	-16.93	-92.1	-	-
Investment in Securities	-88.65	-	-	-	3.28
Investing Cash Flow	-617.03	-218.22	-454.39	-310.04	-315.49
Long-Term Debt Issued	127	305.59	622.91	285.67	148.91
Long-Term Debt Repaid	-745.51	-190.67	-208	-7.54	-7.54
Total Debt Repaid	-745.51	-190.67	-208	-7.54	-7.54
Net Debt Issued (Repaid)	-618.51	114.92	414.92	278.13	141.38
Issuance of Common Stock	1,182	-	-	-	-
Common Dividends Paid	-86.39	-14.01	-	-	-15.66
Other Financing Activities	-40.38	-	-	-	-
Financing Cash Flow	436.27	100.92	414.92	278.13	125.71
Net Cash Flow	0.07	22.36	0.6	-42.88	7.94
Free Cash Flow	-284.27	-56.66	-343.12	-318.15	-120.76
Free Cash Flow Margin	-20.07%	-4.71%	-35.05%	-38.99%	-17.21%
Free Cash Flow Per Share	-6.44	-1.62	-9.80	-9.09	-1207.55
Cash Interest Paid	20.48	78.55	24.02	10	1.14
Levered Free Cash Flow	-354.84	-68.71	-369.73	-359.89	-122.63
Unlevered Free Cash Flow	-344.14	-19.4	-357.82	-351.6	-121.7
Change in Working Capital	-147.89	-67.58	-140.33	-136.33	91.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.